Rice Hall James & Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Buy |
1,591,575
+22,363
| +1% | +$38.5K | 0.15% | 136 |
|
|
2025
Q1 | $5.23M | Sell |
1,569,212
-25,320
| -2% | -$84.3K | 0.31% | 73 |
|
|
2024
Q4 | $11.8M | Sell |
1,594,532
-84,625
| -5% | -$626K | 0.65% | 46 |
|
|
2024
Q3 | $15.8M | Buy |
1,679,157
+43,132
| +3% | +$405K | 0.85% | 31 |
|
|
2024
Q2 | $13.1M | Sell |
1,636,025
-77,800
| -5% | -$624K | 0.79% | 36 |
|
|
2024
Q1 | $25.4M | Sell |
1,713,825
-37,082
| -2% | -$550K | 1.45% | 17 |
|
|
2023
Q4 | $14.2M | Buy |
1,750,907
+28,196
| +2% | +$229K | 0.82% | 38 |
|
|
2023
Q3 | $7.84M | Sell |
1,722,711
-36,048
| -2% | -$164K | 0.5% | 54 |
|
|
2023
Q2 | $12.4M | Buy |
1,758,759
+28,795
| +2% | +$203K | 0.7% | 45 |
|
|
2023
Q1 | $10.6M | Sell |
1,729,964
-92,116
| -5% | -$563K | 0.6% | 46 |
|
|
2022
Q4 | $11.6M | Buy |
1,822,080
+388,024
| +27% | +$2.48M | 0.67% | 42 |
|
|
2022
Q3 | $13.7M | Sell |
1,434,056
-267,135
| -16% | -$2.56M | 0.8% | 40 |
|
|
2022
Q2 | $18.8M | Buy |
1,701,191
+616,070
| +57% | +$6.8M | 0.91% | 34 |
|
|
2022
Q1 | $18.1M | Buy |
1,085,121
+453,337
| +72% | +$7.55M | 0.72% | 43 |
|
|
2021
Q4 | $12.1M | Sell |
631,784
-230,163
| -27% | -$4.39M | 0.43% | 56 |
|
|
2021
Q3 | $21.3M | Sell |
861,947
-21,448
| -2% | -$529K | 0.79% | 43 |
|
|
2021
Q2 | $23M | Buy |
883,395
+177,468
| +25% | +$4.62M | 0.82% | 40 |
|
|
2021
Q1 | $22.4M | Sell |
705,927
-5,471
| -0.8% | -$173K | 0.73% | 44 |
|
|
2020
Q4 | $33M | Sell |
711,398
-28,472
| -4% | -$1.32M | 1.16% | 30 |
|
|
2020
Q3 | $24.4M | Buy |
739,870
+59,933
| +9% | +$1.97M | 0.98% | 33 |
|
|
2020
Q2 | $18.7M | Buy |
679,937
+227,595
| +50% | +$6.25M | 0.8% | 38 |
|
|
2020
Q1 | $13.5M | Buy |
+452,342
| New | +$13.5M | 0.76% | 43 |
|